The Bone Morphogenetic Protein Pathway Is Inactivated in the Majority of Sporadic Colorectal Cancers
To access this article, please choose from the options below
Supported by an EC FP6 grant for tumor host genomics (to E.W.) and the Dutch Cancer Society (L.L.K.).
The authors report that there is no conflict of interest to disclose.
PII: S0016-5085(08)00347-8
doi:10.1053/j.gastro.2008.02.059
© 2008 AGA Institute. Published by Elsevier Inc. All rights reserved.

